Sprachen

  1. Forschung
  2. Veröffentlichungen

Veröffentlichungen

Filter: Autor is Broocks, A  [Alle Filter zurücksetzen]
1997
Broocks A, Meyer TF, Bandelow B, et al. "Exercise avoidance and impaired endurance capacity in patients with panic disorder." Neuropsychobiology. 1997;36(4):182-7.
Broocks A, Meyer TF, Georg A, et al. "Zum Stellenwert von Sport in der Behandlung psychischer Erkrankungen." Psychother Psychosom med Psychol . 1997;47:379-393.
1998
Broocks A, Bandelow B, Pekrun G, et al. "Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder." Am J Psychiatry. 1998;155(5):603-9.
Meyer T, Broocks A, Bandelow B, Hillmer-Vogel U, Rüther E. "Endurance training in panic patients: spiroergometric and clinical effects." Int J Sports Med. 1998;19(7):496-502.
1999
Broocks A, Meyer T, George A, et al. "Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners." Neuropsychopharmacology. 1999;20(2):150-61.
Broocks A, Meyer TF, Bandelow B. "The Role of Aerobic Exercise in the Treatment of Panic Disorder." Directions in Psychiatry . 1999;19:163-175.
2000
Meyer T, Broocks A. "Therapeutic impact of exercise on psychiatric diseases: guidelines for exercise testing and prescription." Sports Med. 2000;30(4):269-79.
Bandelow B, Broocks A, Pekrun G, et al. "The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial." Pharmacopsychiatry. 2000;33(5):174-81.
2001
Broocks A, Meyer T, Gleiter CH, et al. "Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects." Psychopharmacology (Berl.). 2001;155(3):234-41.
2008
Huber G, Broocks A, Meyer T. "Bewegung und seelische Gesundheit." Psychotherapie im Dialog. 2008;9:357-364.